M&A Deal Summary

PPD Acquires InnoPharm

On September 22, 2008, PPD acquired life science company InnoPharm

Acquisition Highlights
  • This is PPD’s 1st transaction in the Life Science sector.
  • This is PPD’s 1st transaction in Russia.

M&A Deal Summary

Date 2008-09-22
Target InnoPharm
Sector Life Science
Buyer(s) PPD
Deal Type Add-on Acquisition

Target

InnoPharm

Smolensk, Russia
InnoPharm Ltd. is a Contract Research Organization (CRO), provides clinical trial research and management services to pharmaceutical companies.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

PPD

Wilmington, North Carolina, United States

Category Company
Founded 1985
Sector Life Science
Employees26,000
Revenue 4.7B USD (2020)
DESCRIPTION

PPD is a global contract research organization providing drug discovery, development, and lifecycle management services. Its clients and partners primarily include pharmaceutical and biotechnology companies, in addition to medical device companies, academic institutions, and government organizations. With offices in 44 countries and more than 11,000 professionals worldwide, PPDI applies innovative technologies, therapeutic expertise, and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. PPD was founded in 1985 and is based in Wilmington, North Carolina.


DEAL STATS #
Overall 1 of 8
Sector: Life Science M&A 1 of 6
Type: Add-on Acquisition M&A Deals 1 of 7
Country: Russia M&A 1 of 1
Year: 2008 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-04-01 Magen BioSciences

Waltham, Massachusetts, United States

Magen BioSciences, Inc. is a provider of research and development for pharmaceutical products for the improvement of human skin.

Buy -